GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (OTCPK:ATGGF) » Definitions » Short-Term Capital Lease Obligation

Actinogen Medical (Actinogen Medical) Short-Term Capital Lease Obligation : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Actinogen Medical Short-Term Capital Lease Obligation?

Actinogen Medical's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil.

Actinogen Medical's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($0.06 Mil) but then declined from Jun. 2023 ($0.06 Mil) to Dec. 2023 ($0.00 Mil).

Actinogen Medical's annual Short-Term Capital Lease Obligation increased from Jun. 2021 ($0.05 Mil) to Jun. 2022 ($0.06 Mil) and increased from Jun. 2022 ($0.06 Mil) to Jun. 2023 ($0.06 Mil).

Actinogen Medical Short-Term Capital Lease Obligation Historical Data

The historical data trend for Actinogen Medical's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Short-Term Capital Lease Obligation Chart

Actinogen Medical Annual Data
Trend Jun13 Jun14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.06 0.05 0.06 0.06

Actinogen Medical Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.06 - 0.06 -

Actinogen Medical Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Actinogen Medical Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical (Actinogen Medical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (OTCPK:ATGGF) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
ASX:AGN ASX:OCC ASX:SPL ASX:ADO ASX:BIT ASX:PAR ASX:PAA ASX:PTX ASX:EZZ ASX:CYP OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
3AC:Germany ACW:Australia
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Website
https://www.actinogen.com.au
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.